Literature DB >> 23349131

Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.

Jérôme Avouac1, Dörte Huscher, Daniel E Furst, Christian F Opitz, Oliver Distler, Yannick Allanore.   

Abstract

OBJECTIVE: To establish an expert consensus on which criteria are the most appropriate in clinical practice to refer patients with systemic sclerosis (SSc) for right heart catheterisation (RHC) when pulmonary hypertension (PH) is suspected.
METHODS: A three stage internet based Delphi consensus exercise involving worldwide PH experts was designed. In the first stage, a comprehensive list of domains and items combining evidence based indications and expert opinions were obtained. In the second and third stages, experts were asked to rate each item selected in the list. After each of stages 2 and 3, the number of items and criteria were reduced according to a cluster analysis.
RESULTS: A literature search and the opinions of 47 experts participating in Delphi stage 1 provided a list of seven domains containing 142 criteria. After stages 2 and 3, these domains and tools were reduced to three domains containing eight tools: clinical (progressive dyspnoea over the past 3 months, unexplained dyspnoea, worsening of WHO dyspnoea functional class, any finding on physical examination suggestive of elevated right heart pressures and any sign of right heart failure), echocardiography (systolic pulmonary artery pressure >45 mm Hg and right ventricle dilation) and pulmonary function tests (diffusion lung capacity for carbon monoxide <50% without pulmonary fibrosis).
CONCLUSIONS: Among experts in pulmonary arterial hypertension-SSc, a core set of criteria for clinical practice to refer SSc patients for RHC has been defined by Delphi consensus methods. Although these indications are recommended by this expert group to be used as an interim tool, it will be necessary to formally validate the present tools in further studies.

Entities:  

Keywords:  Multidisciplinary team-care; Outcomes research; Systemic Sclerosis

Mesh:

Year:  2013        PMID: 23349131     DOI: 10.1136/annrheumdis-2012-202567

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

Review 1.  Personalized medicine in systemic sclerosis: facts and promises.

Authors:  Rucsandra Dobrota; Carina Mihai; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.592

2.  The heterogeneity of clinical practice patterns among an international cohort of pulmonary arterial hypertension experts.

Authors:  John J Ryan; Ghazwan Butrous; Bradley A Maron
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

3.  Treatment differences in pulmonary arterial hypertension management.

Authors:  Bradley A Maron; John J Ryan
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

4.  Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease.

Authors:  Marius George Linguraru; John A Pura; Mark T Gladwin; Antony I Koroulakis; Caterina Minniti; Roberto F Machado; Gregory J Kato; Bradford J Wood
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

Review 5.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

Review 6.  A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

Authors:  Lesley Ann Saketkoo; Tracy Frech; Cecília Varjú; Robyn Domsic; Jessica Farrell; Jessica K Gordon; Carina Mihai; Nora Sandorfi; Lee Shapiro; Janet Poole; Elizabeth R Volkmann; Monika Lammi; Kendra McAnally; Helene Alexanderson; Henrik Pettersson; Faye Hant; Masataka Kuwana; Ami A Shah; Vanessa Smith; Vivien Hsu; Otylia Kowal-Bielecka; Shervin Assassi; Maurizio Cutolo; Cristiane Kayser; Victoria K Shanmugam; Madelon C Vonk; Kim Fligelstone; Nancy Baldwin; Kerri Connolly; Anneliese Ronnow; Beata Toth; Maureen Suave; Sue Farrington; Elana J Bernstein; Leslie J Crofford; László Czirják; Kelly Jensen; Monique Hinchclif; Marie Hudson; Matthew R Lammi; Jennifer Mansour; Nadia D Morgan; Fabian Mendoza; Mandana Nikpour; John Pauling; Gabriela Riemekasten; Anne-Marie Russell; Mary Beth Scholand; Elise Seigart; Tatiana Sofia Rodriguez-Reyna; Laura Hummers; Ulrich Walker; Virginia Steen
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-09-15       Impact factor: 4.991

Review 7.  The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Authors:  Lesley Ann Saketkoo; Jeanette H Magnus; Mittie K Doyle
Journal:  Am J Med Sci       Date:  2014-01       Impact factor: 2.378

8.  Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Christian Nagel; Philipp Henn; Nicola Ehlken; Antonello D'Andrea; Norbert Blank; Eduardo Bossone; Anke Böttger; Christoph Fiehn; Christine Fischer; Hanns-Martin Lorenz; Frank Stöckl; Ekkehard Grünig; Benjamin Egenlauf
Journal:  Arthritis Res Ther       Date:  2015-06-19       Impact factor: 5.156

Review 9.  Extrahepatic Manifestations of Primary Biliary Cholangitis.

Authors:  Sara L Chalifoux; Peter G Konyn; Gina Choi; Sammy Saab
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

10.  Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.

Authors:  J Gerry Coghlan; Christopher P Denton; Ekkehard Grünig; Diana Bonderman; Oliver Distler; Dinesh Khanna; Ulf Müller-Ladner; Janet E Pope; Madelon C Vonk; Martin Doelberg; Harbajan Chadha-Boreham; Harald Heinzl; Daniel M Rosenberg; Vallerie V McLaughlin; James R Seibold
Journal:  Ann Rheum Dis       Date:  2013-05-18       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.